Discussing Genitourinary (GU) Cancers ASCO 2022 Practice changing studies with Dr. Shilpa Gupta, Director of Taussig Cancer Institute and Co-Leader GU Onc, Cleveland Clinic GU Malignancy. Tags: Dr. Shilpa Gupta (GU) ASCO 2022 Genitourinary Share this: Related posts Conferences SABCS 2024 SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA Jan 09, 2025 Conferences ASH 2024 Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski Jan 07, 2025 You might be interested in ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL, Role of CAR-T Cell Therapy Dec 26, 2024 Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens Dec 19, 2024